Gene Therapy
	Cold Spring Harbor Laboratory , Cold Spring Harbor, NY September 25 - 29, 2000
	• Viral Vector Development & Regulation of Gene Expression • Disease Models I - Hematopoiesis, Hemophilia & Muscle Disorders • Immunity and Gene Transfer • Genetic Approaches and Immunotherapy for Cancer & Angiogenesis • Gene Therapy for AIDS and Vaccination Approaches to Infectious Diseases • Disease models II - Neurological, Metabolic & Cardiovascular • New Technology, Stem Cells & Tissue Engineering • Special Panel Discussion: Clinical Trials Design, Data Safety, Monitoring & Bioethics Panelists: Michael Blaese (ValiGen), Raphael Dolin (Harvard), Jay Siegel (FDA), Kathryn Zoon (FDA)
	Organized by:	Jeffrey Leiden, Harvard School of Public Health/Harvard Medical School, Margaret Liu, Lafayette, California, Gary Nabel, National Institutes of Health, James Wilson, University of Pennsylvania
	Invited Speakers:	Invited Speakers/Discussion Leaders: Malcolm Brenner (Houston) Jeffrey Bonadio (San Diego) Hermann Bujard, (Heidelberg, Germany) Marina Cavazzana, (INSERM, France) Olivier Danos (Evry, France) pending Alain Fischer (???) Judah Folkman (Boston) Theodore Friedmann (San Diego) Fred Gage (San Diego) Katherine High (Philadelphia) Ronald Levy (Stanford) Bruce Sullenger (Durham) Didier Trono (Geneva, Switzerland) Inder Verma (San Diego) Savio Woo (New York) John Young (Madison)
	Deadline for Abstracts:	July 5
	Registration:	Register online
	Email for Requests and Registration:	Meetings@cshl.org
	Posted by: Michael Glaessgen   Host: talon.cshl.org date: June 14, 2000 16:16:41 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.